ArticleCancer management and research2020

The Effect and Safety of Anti-PD-1 Single/Combination Therapy in Refractory Thymic Carcinoma: A Case-Series Study.

Wei Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.